top of page

News Archives

PRESS RELEASES

​

July 12, 2018 - Ceres Nanosciences’ Point-of-Care Nanotrap® Lyme Antigen Test System Granted Breakthrough Device Designation by U.S. Food and Drug Administration

​

May 31, 2018 - Ceres Nanosciences reaches product development milestone for point-of-care Lyme disease test and closes on an additional $5.5M of Series A funding  

​

December 12, 2017 - Ceres announces major expansion with new Nanotrap® particle manufacturing site in Northern Virginia 

​

September 28, 2017 - Ceres part of team receiving $4.25MM from the DOD to develop a universal surveillance platform for infectious disease outbreaks

​

February 22, 2017 - Ceres receives $750K award from DARPA to adapt Nanotrap® platform to detect Zika and other febrile illnesses

 

February 2, 2017 - Ceres announces $9MM Series A investment round with initial $3MM investment from GreyBird Ventures

 

July 6, 2016 - Ceres receives $980K award from DARPA/US Department of Defense to adapt Nanotrap® to capture immune markers from non-invasive samples

​

November 10, 2015 - Ceres Nanosciences announces the publication of pioneering clinical study to develop urine based Lyme Antigen Test. 

 

June 29, 2015 - Ceres receives $746K from the Bill & Melinda Gates Foundation to use the Nanotrap® to develop a highly sensitive, rapid test for Tuberculosis in urine

 

March 11, 2015 - Ceres partners with Johns Hopkins to evaluate Nanotrap® saliva test for Malaria

 

December 2, 2014 - Ceres receives $430K in funding for Ebola test development program from the Bill & Melinda Gates Foundation. Will use Nanotrap® to screen for Ebola Virus in saliva at earliest stages of infection

 

July 10, 2014 - TGen and Ceres Nanosciences announce collaboration to develop high-throughput Nanotrap® enrichment methods for Mass Spectrometry

 

July 10, 2013 - Ceres Nanosciences awarded Phase II funding to develop Nanotrap® enhanced detection platform for Rift Valley Fever Virus 

 

May 30, 2013 - Ceres Nanosciences awarded funding from Virginia Commercialization program to further development of Nanotrap® Universal Sample Collection Toolset 

 

September 9, 2012 - Ceres Nanosciences awarded DARPA Phase II SBIR to develop Nanotrap® Universal Sample Collection Toolset 

 

May 23, 2011 - Ceres Nanosciences announces issuance of two Nanotrap® patents 

 

February 22, 2011 - Ceres Nanosciences awarded 250K to develop Nanotrap® based universal sample preparation tool for Rift Valley Fever Virus 

 

April 13, 2010 - Ceres Nanosciences completes USADA funded clinical study to measure HGH in urine and establish initial human baseline levels 

 

April 22, 2009 - Ceres Nanosciences and SAIC-Frederick Collaborate On Cancer Steroid Hormone Studies using Nanotrap® platform

 

March 1, 2009 - Ceres Nanosciences and USADA Join To Advance Research Aimed at Developing an HGH Urine-Based Test for Benefit of Clean Sport 

 

July 21, 2008 - Ceres Nanosciences to Develop Nanotechnology Products for Health Care, Industry and Government Applications 

​

NEWS PUBLICATIONS

​

August 7, 2018  - Hope for Lyme disease victims: Researchers race to develop new tests — and a vaccine

CNBC

​

August 1, 2018  - Comstock: Putting a Bullseye on Lyme Disease

Loudoun Now

​

July 20, 2018  - Manassas firm gets step closer to new urine test for Lyme disease

The Washington Business Journal

​

May 25, 2018  - Episode 43: If You Build It…We Will Grow

The Project Podcast: Inside Corporate Location Decisions

​

March 12, 2018 Potential New Clinical Laboratory Urine Test for TB Could Speed Up Diagnosis and Treatment of Disease That Kills 1.7 Million People Each Year

Dark Daily

​

January 1, 2018 Fast, Cheap Testing for Tuberculosis? Soon It May Be Possible

New York Times

​

September 28, 2017 DoD funds research to monitor infectious disease

STAT News

​

February 7, 2017  - A technology backed by Bill Gates may revolutionize diagnostics for Lyme disease

CNBC

​

October 7, 2016  - Ceres CEO, Ross Dunlap on the Science Behind Ceres Nanosciences (VIDEO)

ACG National Capital - Annual Growth Conference

 

September 22, 2016  - Ceres receives award for being one of the Washington area's most innovative companies

Washington Business Journal

 

June 1, 2016  - Early-Detection Urine Test Is Effective for Lyme Disease

Labmedica 

 

February 12, 2016  - Researchers discover early Lyme Disease detection

WJLA ABC7 News Report

 

November 24, 2015  - George Mason University spinoff plans to disrupt the diagnostics market

Washington Business Journal

 

November 20, 2015 -  Ceres Wins $500K From VBHRC to Further Develop Lyme Dx; Begins Offering Test Nationwide

GenomeWeb

 

May 12, 2015 - New Lyme disease test in clinical phase at Northern Virginia lab

Loudoun Times Mirror

 

March 11, 2015 - Johns Hopkins Researchers to Evaluate Malaria Saliva Test

Global Biodefense

 

July 29, 2013 - Researcher Returns to Africa with New Way to "Trap" Deadly Virus

George Mason University

 

July 15, 2013 - Taking the mystery out of Lyme disease

The Fairfax Times 

 

September 15, 2011 - Ceres Nanosciences' scientist awarded Popular Science's "Brilliant 10" award for Nanotrap® work

Popular Science 

 

February 2, 2010 - Shimadzu, Ceres Nanosciences And Nonlinear Dynamics Introduce Nanotrap® Biomarker Discovery Platform

Biocompare 

 

April 22, 2009 - Ceres Nanosciences and SAIC-Frederick Collaborate On Cancer Steroid Hormone Studies

Nanowerk

 

February 26, 2009 - USADA will help fund further study of urine test for HGH

USA Today

 

December 17, 2008 - Pioneering mind-set at George Mason produces new HGH test

USA Today

 

December 20, 2008 - Urine test for HGH gets boost from scientific journal

USA Today

 

November 17, 2008  - Professors, Entrepreneurs Seek Synergies

The Washington Post

 

July 23, 2008 - Scientists say breakthrough urine test for HGH developed

USA Today

 

July 18, 2008 - GMU spinoff hopes nanotech product is a home run

Washington Business Journal

 

February 27, 2008 - In a Va. Lab, Forging Links To Speed Cancer Advances

The Washington Post

bottom of page